SCHEMBL8062889

SCHEMBL8062889

C=CC[C@@H](c1ccc(Cl)c(Cl)c1)C(C)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.36
SLC6A2 P23975 6/20 0.36
SLC6A3 Q01959 6/20 0.36
CYP3A4 P08684 4/20 0.36
CYP2D6 P10635 4/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AAK1 Q2M2I8 1/20 0.35
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8062891 1.00 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8062537 0.90 SLC6A4 (0.37) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8579734 0.84 ALDH1A1 (0.36) SLC6A4SLC6A2SLC6A3ALDH1A1LMNA
SCHEMBL8579732 0.84 ALDH1A1 (0.36) SLC6A4SLC6A2SLC6A3ALDH1A1LMNA
SCHEMBL8062813 0.72 PNMT (0.41) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8062809 0.72 PNMT (0.41) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8580760 0.72 PNMT (0.41) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL6585584 0.72 S1PR3 (0.43) SLC6A4SLC6A2SLC6A3ALDH1A1LMNA
SCHEMBL6585577 0.72 S1PR3 (0.43) SLC6A4SLC6A2SLC6A3ALDH1A1LMNA
SCHEMBL4630832 0.72 SLC6A3 (0.35) SLC6A4SLC6A2SLC6A3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013652-A ANTIINFLAMMATORY AGENTS; ANALGESICS; ANTIHISTAMINES MERCK & CO., INC. (US) 2000-01-11 US disclosed
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
WO-1998025605-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
EP-0702681-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1996-03-27 EP disclosed
WO-1994029309-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1994-12-22 WO disclosed